Genesis Financial Group LLC Makes New Investment in Astera Labs, Inc. $ALAB

Genesis Financial Group LLC purchased a new position in shares of Astera Labs, Inc. (NASDAQ:ALAB) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 10,900 shares of the company’s stock, valued at approximately $1,813,000. Astera Labs makes up about 1.1% of Genesis Financial Group LLC’s investment portfolio, making the stock its 28th biggest holding.

Several other institutional investors and hedge funds also recently made changes to their positions in ALAB. Royal Bank of Canada raised its stake in Astera Labs by 167.3% during the 1st quarter. Royal Bank of Canada now owns 152,453 shares of the company’s stock worth $9,097,000 after buying an additional 95,409 shares during the period. AQR Capital Management LLC grew its stake in Astera Labs by 213.4% in the first quarter. AQR Capital Management LLC now owns 11,391 shares of the company’s stock valued at $680,000 after acquiring an additional 7,756 shares during the period. Empowered Funds LLC grew its stake in Astera Labs by 917.3% in the first quarter. Empowered Funds LLC now owns 4,639 shares of the company’s stock valued at $277,000 after acquiring an additional 4,183 shares during the period. Cetera Investment Advisers increased its holdings in shares of Astera Labs by 167.1% in the second quarter. Cetera Investment Advisers now owns 9,131 shares of the company’s stock worth $826,000 after acquiring an additional 5,712 shares in the last quarter. Finally, American Century Companies Inc. increased its holdings in shares of Astera Labs by 383.4% in the second quarter. American Century Companies Inc. now owns 32,791 shares of the company’s stock worth $2,965,000 after acquiring an additional 26,008 shares in the last quarter. Institutional investors and hedge funds own 60.47% of the company’s stock.

Insider Activity at Astera Labs

In related news, CEO Jitendra Mohan sold 157,500 shares of the stock in a transaction on Tuesday, March 17th. The shares were sold at an average price of $131.58, for a total transaction of $20,723,850.00. Following the completion of the transaction, the chief executive officer owned 4,531,732 shares in the company, valued at approximately $596,285,296.56. This represents a 3.36% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, General Counsel Philip Mazzara sold 10,000 shares of the firm’s stock in a transaction on Monday, March 2nd. The shares were sold at an average price of $117.47, for a total transaction of $1,174,700.00. Following the completion of the transaction, the general counsel directly owned 128,084 shares of the company’s stock, valued at approximately $15,046,027.48. This trade represents a 7.24% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last ninety days, insiders sold 384,292 shares of company stock worth $48,724,919. 12.50% of the stock is currently owned by corporate insiders.

Astera Labs Price Performance

ALAB stock opened at $117.14 on Friday. The stock has a market capitalization of $20.06 billion, a P/E ratio of 96.02, a P/E/G ratio of 2.09 and a beta of 1.78. Astera Labs, Inc. has a fifty-two week low of $47.13 and a fifty-two week high of $262.90. The business has a 50-day moving average of $132.61 and a 200-day moving average of $160.43.

Astera Labs (NASDAQ:ALAB) last announced its earnings results on Tuesday, February 10th. The company reported $0.58 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.51 by $0.07. The business had revenue of $270.58 million for the quarter, compared to analyst estimates of $249.46 million. Astera Labs had a return on equity of 16.12% and a net margin of 25.70%.Astera Labs’s revenue for the quarter was up 91.8% compared to the same quarter last year. During the same quarter last year, the firm earned $0.37 EPS. Astera Labs has set its Q1 2026 guidance at 0.530-0.540 EPS. Equities analysts expect that Astera Labs, Inc. will post 0.34 EPS for the current year.

Analysts Set New Price Targets

Several equities analysts have recently weighed in on ALAB shares. Weiss Ratings cut Astera Labs from a “hold (c-)” rating to a “sell (d+)” rating in a report on Monday, February 23rd. Citigroup initiated coverage on Astera Labs in a research note on Thursday. They set a “buy” rating and a $200.00 target price for the company. Barclays set a $165.00 target price on shares of Astera Labs in a report on Thursday, January 15th. Royal Bank Of Canada initiated coverage on shares of Astera Labs in a report on Wednesday, January 14th. They issued an “outperform” rating and a $225.00 price target for the company. Finally, Loop Capital started coverage on shares of Astera Labs in a research report on Thursday, March 5th. They set a “buy” rating and a $250.00 price objective for the company. Fifteen research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, Astera Labs presently has an average rating of “Moderate Buy” and an average price target of $199.44.

Astera Labs Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.